BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. Clin Oncol (R Coll Radiol) 2015;27:579-87. [PMID: 26166774 DOI: 10.1016/j.clon.2015.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Xu L, Osei B, Osei E. A review of radiation genomics: integrating patient radiation response with genomics for personalised and targeted radiation therapy. J Radiother Pract 2019;18:198-209. [DOI: 10.1017/s1460396918000547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Burnet NG, Scaife JE, Romanchikova M, Thomas SJ, Bates AM, Wong E, Noble DJ, Shelley LE, Bond SJ, Forman JR, Hoole AC, Barnett GC, Brochu FM, Simmons MP, Jena R, Harrison K, Yeap PL, Drew A, Silvester E, Elwood P, Pullen H, Sultana A, Seah SY, Wilson MZ, Russell SG, Benson RJ, Rimmer YL, Jefferies SJ, Taku N, Gurnell M, Powlson AS, Schönlieb CB, Cai X, Sutcliffe MP, Parker MA. Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary 'VoxTox' research programme. CERN Ideasq J Exp Innov 2017;1:3-12. [PMID: 29177202 DOI: 10.23726/cij.2017.457] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
3 West CM, Huddart RA. Biomarkers and Imaging for Precision Radiotherapy. Clin Oncol (R Coll Radiol) 2015;27:545-6. [PMID: 26173954 DOI: 10.1016/j.clon.2015.06.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Vinnikov V, Hande MP, Wilkins R, Wojcik A, Zubizarreta E, Belyakov O. Prediction of the Acute or Late Radiation Toxicity Effects in Radiotherapy Patients Using Ex Vivo Induced Biodosimetric Markers: A Review. J Pers Med 2020;10:E285. [PMID: 33339312 DOI: 10.3390/jpm10040285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ocolotobiche EE, Banegas YC, Güerci AM. Modulation of ionizing radiation-induced damage in human blood lymphocytes by in vivo treatment with resveratrol. Int J Radiat Biol 2019;95:1220-5. [PMID: 31140903 DOI: 10.1080/09553002.2019.1625489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Baijer J, Déchamps N, Perdry H, Morales P, Kerns S, Vasilescu A, Baulande S, Azria D, Roméo PH, Schmitz A. TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis. Oncotarget 2016;7:21416-27. [PMID: 26982083 DOI: 10.18632/oncotarget.7893] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
7 Herskind C, Talbot CJ, Kerns SL, Veldwijk MR, Rosenstein BS, West CM. Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Lett 2016;382:95-109. [PMID: 26944314 DOI: 10.1016/j.canlet.2016.02.035] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
8 Fhoghlú MN, Barrett S. A Review of Radiation-Induced Lymphocyte Apoptosis as a Predictor of Late Toxicity After Breast Radiotherapy. J Med Imaging Radiat Sci 2019;50:337-44. [PMID: 31176443 DOI: 10.1016/j.jmir.2019.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, Stock R, Stone NN, Sydes MR, Tyrer JP, Ahmed S, Parliament M, Ostrer H, Rosenstein BS, Vega A, Burnet NG, Dunning AM, Barnett GC, West CM; Radiogenomics Consortium. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. EBioMedicine 2016;10:150-63. [PMID: 27515689 DOI: 10.1016/j.ebiom.2016.07.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
10 Aguado-Barrera ME, Martínez-Calvo L, Fernández-Tajes J, Calvo-Crespo P, Taboada-Valladares B, Lobato-Busto R, Gómez-Caamaño A, Vega A. Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients. Cancers (Basel) 2021;13:1447. [PMID: 33810047 DOI: 10.3390/cancers13061447] [Reference Citation Analysis]
11 Gupta A, Mathew D, Bhat SA, Ghoshal S, Pal A. Genetic Variants of DNA Repair Genes as Predictors of Radiation-Induced Subcutaneous Fibrosis in Oropharyngeal Carcinoma. Front Oncol 2021;11:652049. [PMID: 34079756 DOI: 10.3389/fonc.2021.652049] [Reference Citation Analysis]
12 Ocolotobiche EE, Dauder RM, Güerci AM. Radiosensitivity of radiotherapy patients: The effect of individual DNA repair capacity. Mutat Res Genet Toxicol Environ Mutagen 2021;867:503371. [PMID: 34266627 DOI: 10.1016/j.mrgentox.2021.503371] [Reference Citation Analysis]
13 Borràs-Fresneda M, Barquinero JF, Gomolka M, Hornhardt S, Rössler U, Armengol G, Barrios L. Differences in DNA Repair Capacity, Cell Death and Transcriptional Response after Irradiation between a Radiosensitive and a Radioresistant Cell Line. Sci Rep 2016;6:27043. [PMID: 27245205 DOI: 10.1038/srep27043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
14 De Ruysscher D, Defraene G, Ramaekers BLT, Lambin P, Briers E, Stobart H, Ward T, Bentzen SM, Van Staa T, Azria D, Rosenstein B, Kerns S, West C. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement. Radiother Oncol 2016;121:440-6. [PMID: 27979370 DOI: 10.1016/j.radonc.2016.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
15 Tomasik B, Chałubińska-Fendler J, Chowdhury D, Fendler W. Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy. Transl Res 2018;201:71-83. [PMID: 30021695 DOI: 10.1016/j.trsl.2018.06.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
16 Abraham JA, Yeghiazaryan K, Golubnitschaja O. Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization. Per Med 2016;13:347-60. [PMID: 29749819 DOI: 10.2217/pme-2016-0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Smith WP, Richard PJ, Zeng J, Apisarnthanarax S, Rengan R, Phillips MH. Decision analytic modeling for the economic analysis of proton radiotherapy for non-small cell lung cancer. Transl Lung Cancer Res 2018;7:122-33. [PMID: 29876311 DOI: 10.21037/tlcr.2018.03.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Møller PK, Olling K, Berg M, Habæk I, Haislund B, Iversen AM, Ewertz M, Lorenzen EL, Brink C. Breast cancer patients report reduced sensitivity and pain using a barrier film during radiotherapy - A Danish intra-patient randomized multicentre study. Tech Innov Patient Support Radiat Oncol 2018;7:20-5. [PMID: 32095578 DOI: 10.1016/j.tipsro.2018.05.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Borges da Silva E, Brayner Cavalcanti M, Ferreira Da Silva CS, de Salazar E Fernandes T, Azevedo Melo J, Lucena L, Maciel Netto A, Amaral A. Micronucleus assay for predicting side effects of radiotherapy for cervical cancer. Biotech Histochem 2021;96:60-6. [PMID: 32436746 DOI: 10.1080/10520295.2020.1759143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Mangar S. Radiotherapy versus Prostatectomy: a Question of Survival or Survivorship? Addressing Ongoing Questions and Controversies in the Management of Localised Prostate Cancer in the UK. Clinical Oncology 2016;28:479-81. [DOI: 10.1016/j.clon.2016.04.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Benafif S, Kote-Jarai Z, Eeles RA; PRACTICAL Consortium. A Review of Prostate Cancer Genome-Wide Association Studies (GWAS). Cancer Epidemiol Biomarkers Prev 2018;27:845-57. [PMID: 29348298 DOI: 10.1158/1055-9965.EPI-16-1046] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 14.3] [Reference Citation Analysis]
22 Seibold P, Webb A, Aguado-Barrera ME, Azria D, Bourgier C, Brengues M, Briers E, Bultijnck R, Calvo-Crespo P, Carballo A, Choudhury A, Cicchetti A, Claßen J, Delmastro E, Dunning AM, Elliott RM, Fachal L, Farcy-Jacquet MP, Gabriele P, Garibaldi E, Gómez-Caamaño A, Gutiérrez-Enríquez S, Higginson DS, Johnson K, Lobato-Busto R, Mollà M, Müller A, Payne D, Peleteiro P, Post G, Rancati T, Rattay T, Reyes V, Rosenstein BS, De Ruysscher D, De Santis MC, Schäfer J, Schnabel T, Sperk E, Symonds RP, Stobart H, Taboada-Valladares B, Talbot CJ, Valdagni R, Vega A, Veldeman L, Ward T, Weißenberger C, West CML, Chang-Claude J; REQUITE consortium. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. Radiother Oncol 2019;138:59-67. [PMID: 31146072 DOI: 10.1016/j.radonc.2019.04.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
23 Pavlopoulou A, Bagos PG, Koutsandrea V, Georgakilas AG. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach. Cancer Letters 2017;403:37-47. [DOI: 10.1016/j.canlet.2017.05.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
24 Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes. Sci Rep 2017;7:43381. [PMID: 28233873 DOI: 10.1038/srep43381] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
25 Azria D, Bourgier C, Brengues M. One Size Fits All: Does the Dogma Stand in Radiation Oncology? EBioMedicine 2016;10:19-20. [PMID: 27453323 DOI: 10.1016/j.ebiom.2016.07.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Rattay T, Symonds RP, Shokuhi S, Talbot CJ, Schnur JB. The Patient Perspective on Radiogenomics Testing for Breast Radiation Toxicity. Clin Oncol (R Coll Radiol) 2018;30:151-7. [PMID: 29287972 DOI: 10.1016/j.clon.2017.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
27 Brengues M, Lapierre A, Bourgier C, Pèlegrin A, Özsahin M, Azria D. T lymphocytes to predict radiation-induced late effects in normal tissues. Expert Review of Molecular Diagnostics 2016;17:119-27. [DOI: 10.1080/14737159.2017.1271715] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
28 Asadollahi R, Britschgi C, Joset P, Oneda B, Schindler D, Meier UR, Rauch A. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene). Mol Genet Genomic Med 2020;8:e1409. [PMID: 32748564 DOI: 10.1002/mgg3.1409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]